Now livetag icon
The future of market intelligence is here. Meet AI Studio — your AI-powered Similarweb expertLearn morebanner icon
Abzena

February 2026

Abzena Market Share Analysis for February 2026

Abzena is a fully integrated biologics and bioconjugates CDMO+CRO for antibodies, ADCs, AOCs, RDCs, vaccines, from discovery thru commercial.
Year Founded2001
Employees501 - 1000
Annual Revenue$100M - $200M
abzena.com
Abzena
Abzena (including company regionals)
  • abzena.com
    abzena.com
See more website traffic and engagement information

Abzena Revenue up to February 2026 is 100M - 200M

revenue generated by Abzena top domains

Abzena top domains revenue over 3 years

Revenue for Abzena top domains


Total visits to Abzena's top domains

Understand Abzena market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Abzena's top domains

Analyze Abzena engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Abzena's top domains

See how Abzena keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Abzena

These are the website technologies, by industry, used by Abzena top domains

Payment & Currencies (9)

Cart Functionality

Cart Functionality

Advertising (8)

DoubleClick

DoubleClick

Conversion & Analytics (7)

Google Analytics

Google Analytics

Marketing (5)

Google Marketing Platform

Google Marketing Platform

More Technologies

12

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Abzena

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMabqi SAS integrates with Abzena PLC.This collaboration will integrate Mabqi's antibody discovery capabilities with Abzena's development and manufacturing services, offering biopharma customers a more streamlined, end-to-end drug development solution.
NewsAbzena PLC launched two next-generation glutamine synthetase on Sep 15th '25.Abzena enhances abzelectpro(tm) cell line offering with new GS knockout platforms san diego, CA - september 15, 2025 - abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, announced the expansion of its abzelectpro(tm) cell line development (CLD) platform with the launch of two next-generation glutamine synthetase ("GS") knockout CHO-K1 expression systems, including a double knockout ADCC+ platform for afucosylated proteins.
NewsAbzena PLC hired Geoffrey M. Glass as Chief Executive Officer on Jul 23rd '25.Abzena appoints Geoffrey M. Glass as Chief Executive Officer.

See all Abzena signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.